The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development CRISPR-Cas12-based rapid EGFR mutation detection kit.
 
Kei Kunimasa
No Relationships to Disclose
 
Yuya Bando
No Relationships to Disclose
 
Miyako Shiraishi
No Relationships to Disclose
 
Emi Aizawa
No Relationships to Disclose
 
Kazumi Nishino
Honoraria - AstraZeneca Japan; Chugai Pharma; Lilly; Nippon Boehringer Ingelheim; Novartis; Ono Pharmaceutical; Roche
Research Funding - Nippon Boehringer Ingelheim
 
Motohiro Tamiya
Honoraria - Asahi Kasei; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Ono Pharmaceutical
 
Takako Inoue
No Relationships to Disclose
 
Hanako Kuhara
No Relationships to Disclose
 
Hayato Kawachi
No Relationships to Disclose
 
Kika Kuno
No Relationships to Disclose
 
Fumio Imamura
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca; Boehringer Ingelheim; Ono Pharmaceutical
 
Shigenori Iwai
No Relationships to Disclose
 
Toru Kumagai
No Relationships to Disclose
 
Keiichiro Suzuki
No Relationships to Disclose